2026-11-10 · By SEPT AI
The session was anything but a straight line. QQQ traded in a wide band, touching a high of $680.95 before retreating to a low of $667.05, a swing of roughly two percentage points that underscored the tug-of-war between buyers and sellers. SPY similarly ranged between $752.14 and $744.86. The Fear & Greed Index sat at 32, a reading that places sentiment squarely in "fear" territory even as prices edge higher — a divergence that suggests investors are not chasing the tape with conviction.
With the data at hand, the clearest thematic split Tuesday was between companies delivering upside surprises and those tripping over compliance and financing concerns. Health care and biotech names were active on both sides of that ledger, while the small-cap complex showed pockets of extreme volatility. The day's biggest gainers were dominated by low-float, high-volume names, a hallmark of risk-on speculation that stood in contrast to the cautious headline index moves.
TANH was the standout, surging 68.10% to close at $30.56 on volume of 723,536 shares. TTEC rocketed 42.86% to $2.40 on heavy volume of more than 21.3 million shares, and ZIP jumped 40.06% to $6.59. LGVN climbed 36.54% to $2.84, NCI added 35.00% to $6.48, and RKLX rose 30.24% to $12.06. TREO gained 26.96% to $2.59, ZURA advanced 22.22% to $1.43 on volume exceeding 12.7 million shares, and STAK tacked on 20.17% to $4.92.
On the downside, BMGL collapsed 64.13% to $1.93 on volume of nearly 14.7 million shares. MNTK fell 45.16% to $1.19, OMH dropped 39.36% to $16.61 on roughly 19.9 million shares, and EMAT slid 34.41% to $1.22. SKYQ lost 30.38% to $1.18, BYAH declined 29.35% to $1.95, HIMZ shed 28.59% to $9.64, and RKLZ gave back 23.53% to $13.42. PAYS fell 22.65% to $10.14, FISN dropped 21.48% to $2.12, and LTRX slipped 19.89% to $4.39.
Key Earnings
The earnings calendar was crowded, and several reports drove meaningful moves. CoreWeave (CRWV) beat third-quarter estimates on both revenue and earnings and raised its guidance, calling it a breakout quarter — a bright spot for the artificial intelligence infrastructure trade. Azenta (AZTA) posted fourth-quarter adjusted profit of $0.28 per share, well ahead of the $0.11 consensus, with revenue of $167.088 million topping the $160.133 million estimate.
Eastern Co (EML) reported third-quarter adjusted earnings of $0.60 per share, up sharply from $0.13 a year earlier, on sales of $74.976 million versus $55.300 million. Dolphin Entertainment (DLPN) delivered adjusted profit of $0.08 per share against expectations of a $(0.04) loss, with revenue of $16.021 million beating the $15.200 million projection. National CineMedia (NCMI) guided fourth-quarter sales to $117 million–$124 million, comfortably above the $100.2 million estimate.
Telefonica Brasil (VIV) earned $0.30 per share, ahead of the $0.24 consensus, on revenue of $3.117 billion. Vroom (VRM) narrowed its quarterly loss to $2.01 per share from $5.22 a year earlier, though revenue slipped to $38.447 million. Canterbury Park (CPHC) earned $0.18 per share versus $0.10 a year ago. Alto Neuroscience (ANRO) posted a smaller-than-expected loss of $0.54 per share. Orchestra BioMed (OBIO) reported a loss of $0.30 per share, narrower than the $0.40 expected, though revenue of $91,000 missed. Alcon (ALC) beat on adjusted earnings but fell short on revenue. Sonoma Pharmaceuticals (SNOA) narrowed its quarterly loss as revenue climbed, and Stran & Co (SWAG) posted a breakeven quarter with revenue rising to $28.1 million.
On the weaker side, SANUWAVE Health (SNWV) reported a third-quarter loss of $0.16 per share on $8.579 million in sales. Draganfly (DPRO) posted a loss of $0.25 per share, wider than the $0.19 forecast, with revenue of $1.464 million badly missing the $3.160 million estimate. Datacentrex (DTCX) recorded a loss of six cents per share as revenue fell to $1.737 million from $2.449 million. Beachbody (BODI) guided fourth-quarter sales to $38 million–$42 million, below the $47.431 million estimate.
Compliance and Financing Developments
Several companies disclosed material events that weighed on sentiment. GoPro (GPRO) said its third-quarter 2026 financial statements will reflect substantial doubt about its ability to continue as a going concern, and separately disclosed it cannot file its quarterly report on time and is seeking lender waivers after breaching financing covenants. Rent the Runway (RENT), Nextnrg (NXXT), Senti Biosciences (SNTI), Alzamend Neuro (ALZN), and Golden Minerals (AUMN) each filed 8-K reports on major company events, with dilution or compliance risk flagged in several cases.
Capital raises added pressure in the biotech space. PepGen (PEPG) and Prime Medicine (PRME) each launched $125 million common stock offerings, while IM Cannabis (IMCC) registered up to 25,348,613 shares for selling holder L.I.A. Pure Capital.
FDA and Clinical News
Metagenomi Therapeutics (MGX) won FDA clearance to begin human testing of MGX-001, an experimental gene editing treatment for hemophilia A, with first results expected in the second half of 2027. The approval marks a notable regulatory win for the gene-editing space.
Among notable insider positioning trends compiled from recent filings, several names show sustained accumulation. Republic Services (RSG) stands out with 92 insider buys totaling roughly $1.21 billion. Uber (UBER) has drawn three insider buys worth $15.3 million, and MercadoLibre (MELI) has seen three buys totaling $1.2 million. Other names with consistent insider buying include CECO, FBK, GBCI, Loews (L), NHI, CPB, and Taiwan Semiconductor (TSM).
Investors will continue to work through the dense earnings calendar, with the market's reaction to guidance — particularly in AI infrastructure and health care — likely to set the tone. The Fear & Greed Index at 32 suggests sentiment remains fragile, and the wide intraday ranges in QQQ and SPY indicate that conviction is thin. With several companies flagging going-concern issues, delayed filings, and covenant breaches, credit and compliance headlines bear watching. The coming sessions will test whether the modest grind higher can hold or whether the underlying caution reflected in sentiment readings reasserts itself.
Access real-time market data, AI analysis, dark pool activity, and options flow.
Start Free Trial